Literature DB >> 6668452

Cholesterol turnover and metabolism in two patients with abetalipoproteinemia.

D S Goodman, R J Deckelbaum, R H Palmer, R B Dell, R Ramakrishnan, G Delpre, Y Beigel, M Cooper.   

Abstract

Total body turnover of cholesterol was studied in two patients with abetalipoproteinemia, a 32-year-old man and a 31-year-old woman. The patients received [14C]cholesterol intravenously, and the resulting specific activity-time curves (for 40 and 30 weeks, respectively) were fitted with a three-pool model. Parameters were compared with those from studies of cholesterol turnover in 82 normal and hyperlipidemic subjects. A three-pool model gave the best fit for the abetalipoproteinemic patients, as well as for the 82 previously studied subjects, suggesting general applicability of this model. Cholesterol production rates in the two abetalipoproteinemic subjects (0.82 and 0.89 g/day) were close to values predicted for persons of their body weight. Thus, total body turnover rate of cholesterol was quite normal in abetalipoproteinemia, confirming previous reports. Very low values (9.2 and 8.4 g) were found for M1, the size of the rapidly exchanging compartment pool 1, in the two abetalipoproteinemic subjects. These values were well below the values predicted (from the comparison study population) for normal persons of this size with low plasma cholesterol levels. For one patient, total body exchangeable cholesterol was very low, although not significantly below the predicted values for a person of his size. In the second patient, the observed estimate for total body exchangeable cholesterol was well within the range of values predicted for persons of her size with low to extremely low cholesterol levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668452

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Studies on the transfer of tocopherol between lipoproteins.

Authors:  M G Traber; J C Lane; N R Lagmay; H J Kayden
Journal:  Lipids       Date:  1992-09       Impact factor: 1.880

2.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.

Authors:  S G Young; C M Cham; R E Pitas; B J Burri; A Connolly; L Flynn; A S Pappu; J S Wong; R L Hamilton; R V Farese
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Authors:  I J Goldberg; S Holleran; R Ramakrishnan; M Adams; R H Palmer; R B Dell; D S Goodman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

5.  Dietary Iron Repletion Stimulates Hepatic Mobilization of Vitamin A in Previously Iron-Deficient Rats as Determined by Model-Based Compartmental Analysis.

Authors:  Yaqi Li; Cheng-Hsin Wei; Michael H Green; A Catharine Ross
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.